Surgical Hemostat Market Synopsis
Surgical Hemostat Market Size Was Valued at USD 5.25 Billion in 2024 and is Projected to Reach USD 8.95 Billion by 2032, Growing at a CAGR of 6.9% From 2025-2032.
Absorbable Hemostat is used adjunctively in operating procedures to support the control of capillary, vein, and small arterial outflow when ligation or other conservative methods of regulator are impractical or unproductive. Innovative Hemostat cut to size for use in endoscopic procedures.
Hemostats are designed to clamp small blood vessels for outflow control. Another use is to hold and save artificial fascia during undermining and debriding injuries. This equipment is excellent for revealing, exploring, and imagining the deep parts of a wound. Two types of hemostats are generally used in wound care. The typical hemostat is suggested. Better work in minor wounds is often best attended by the 5-inch curved mosquito hemostat with finely serrated jaws.
The hemostatic apparatus exists in different shapes to use in many operating procedures. These hemostats contain Bainbridge Forceps, Adson Forceps, Mosquito Forceps, Crile Forceps, Kelly Forceps, etc. Surgeons choose the best one according to their comfort and surgical needs, Doctor can perform successful operations.
Novel and family goods are developed to control continuous medical discharge in separate surgical bleeding conditions, and their routine and safety profiles are supported by medical studies in a wide range of surgical procedures. The newly promoted powdered distribution form of products, Powder is designed to help in mild-to-moderate intensity hemorrhage in a range of tissue shells including broad or rare surfaces and locations where contact or placement of fabric ORC products may be stimulating or impractical.
Surgical Hemostat Market Trend Analysis
Surgical Hemostat Market Drivers- Increasing the Number of Surgery and Trauma Cases
- Bleeding produced by trauma or surgery is a serious problem for health, and uncontrollable bleeding can result in death. Developing effective, safe, and convenient hemostatic materials is significant. Rapid and active hemostasis can decrease the possibility of the spread of trauma cells with blood. Hemostatic ingredients are the main applications in the field of wound care, and it is also used for hemostasis during malignant trauma surgery.
- Operating care has been a vital factor for health care globally for over a century. Traumatic injuries, cancers, and cardiovascular disease continue to increase, and the impact of operating involvement on the health of the public will always in growing.
- Bleeding is the most feared problem of surgery and a frequent reason for important perioperative injuries. Several red blood cells are used in the operating situation. To transferable problems, transfusion is related to several non-infectious side effects and is attended by extensive costs to the healthcare system. Operating site bleeding leads to transfusion but it can need reoperation and is related to other problems with coagulopathy and hematoma formation. While the surgery is done at the time hemostatic ingredients are used to reduce bleeding.
Surgical Hemostat Market Opportunities- Increasing Prevalence of Cardiovascular Diseases
- In cardiovascular surgery, a great therapeutic requirement for hemostasis is in operating procedures of the heart and coronary veins. Closing abilities to provide suture support in vascular operations are extremely required. Liquid tight suture holes closing on top of accelerating the hemostatic cascade are standards of a hemostasis and sealant area as a dual-action cover in a variety of cardiovascular signals established by evidence-based medication.
- Hemostasis in cardiac surgery is still a severe problem for physicians. Blood and its products are the most valued at the same time unsafe for surgeons. Companies produce numerous biological or non-biological goods, which raise the price of operations, and are existing for this issue. Decision-making and creating solutions are the most significant goods of a cardiac surgeon.
Surgical Hemostat Market Segment Analysis:
Surgical Hemostat Market is Segmented based on Product Type, application, Formulation, end-users and Region
By Type, Thrombin based segment is expected to dominate the market during the forecast period
In the operating process, hemostasis is vital to achievement. Clinical ligation of bleeding vessels or electrocautery of minor vessels fails or is not possible, therefore doctors trust thrombin. Thrombin has several well-studied biological actions, it helps to realize coagulation and hemostasis, from tissue injury and bleeding, exposed collagen, and released tissue influence causes stimulation of the essential and extrinsic coagulation paths.
Thrombin can be performed directly on several cell types. The smooth muscle cell causes vasoconstriction it aids in hemostasis. Activating platelets encourages their combination at the place of the thrombus. Activated thrombin also turns into a mitogen and chemoattractant for neutrophils and fibroblasts, and uniformly induces the formation of vascular endothelial development effect for tissue and vascular renovation and restoration.
By Formulation, Sponge Hemostats segment held the largest in 2024
The sponge is a therapeutic device intended for application to bleeding sides as a hemostatic. Sponge is water-insoluble, off-white, nonelastic, porous, flexible product made from cleaned porcine skin, Gelatin USP Granules, and Water for Injection, USP. It is able to absorb and hold within its spaces, many times its weight of blood and other fluids. Physical surface modification of a gelatin sponge is caused a quickly absorbable hemostat that establishes greater bond and hemostasis to other advanced hemostats.
Gelatin sponges are cheap to manufacture, contain no bloodderived ingredients, can be safely reabsorbed by the body and are effective hemostats. it is used under the care of a health care professional as a topical dressing for the temporary treatment of moderate to severely bleeding wounds such as surgical wounds (post-operative, donor sites, dermatological), cuts, and lacerations and for the treatment of mild bleeding from topical ENT surgical wounds and nosebleeds. It is also indicated for control of bleeding from the skin at percutaneous needle access, vascular access and percutaneous catheter access sites.
Surgical Hemostat Market Regional Insights:
North America Expected to Dominate the Market Over the Forecast period
The U.S. has thousands of hospitals and health centers across all 50 states. While many of these hospitals specialize in certain types of care, the vast majority perform surgeries of some form every?day. For instance, The U.S. hospital that performed the most surgeries in 2023 is Ochsner LSU Health Shreveport - St Mary Medical Center, located in Shreveport, Louisiana. This facility is a leading academic medical center affiliated with Louisiana State University, and it performed an estimated 236,873 surgeries in 2023.
The number of ambulatory operations centers in the US has increased over the past several years. This was partially cancelled by advances in medical technology that made many operations less invasive, allowing them to be performed on an outpatient basis.
Surgical Hemostat Top Key Active Players
- Becton, Dickinson and Company (US)
- Medtronic plc (US)
- Teleflex Corporation (US)
- Baxter International Inc. (US)
- B. Braun Melsungen AG (Germany)
- Stryker Corporation (US)
- CuraMedical BV (Netherlands)
- Gelita Medical GmbH (Germany)
- Integra LifeSciences (US)
- Marine Polymer Technologies, Inc
- Hemostasis LLC (US)
- Artivion, Inc. (U.S.)
- Biom'up (U.S.)
- Medtronic (Ireland)
- Johnson & Johnson Services, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Z-Medica LLC (United States)
- Anika Therapeutics Inc. (US)
- Ethicon Inc. (US) and other Active players
Key Industry Developments in the Surgical Hemostat Market:
- In August 2023, the Teleflex Corporation received U.S. FDA clearance for its QuickPort Control+ Hemostatic Device. This device helps surgeons to control bleeding during cardiac surgical procedures. Therefore, approval of this product helped the company to enhance its product offerings.
- In November 2023, Ethicon announced CE mark approval for its adjunctive hemostat solution ETHIZIA. ETHIZIA Hemostatic Sealing Patch is used for disrupting bleeding on internal organs, except neurological and cardiovascular. This helped company to strengthen its product portfolio.
|
Global Surgical Hemostat Market |
|||
|
Base Year: |
2024 |
Forecast Period: |
2025-2032 |
|
Historical Data: |
2018 to 2023 |
Market Size in 2024: |
USD 5.25 Bn. |
|
Forecast Period 2024-32 CAGR: |
6.9 % |
Market Size in 2032: |
USD 8.95 Bn. |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By Formulation |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Surgical Hemostat Market by Product Type (2018-2032)
4.1 Surgical Hemostat Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Thrombin Based
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Oxidized Regenerated Cellulose Based
4.5 Gelatin Based
4.6 Collagen Based Hemostat
4.7 Others
Chapter 5: Surgical Hemostat Market by Application (2018-2032)
5.1 Surgical Hemostat Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Neurological Surgery
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Orthopedic Surgery
5.5 Cardiovascular Surgery
5.6 Gynecological Surgery
5.7 Trauma
5.8 Plastic Surgery
5.9 Others
Chapter 6: Surgical Hemostat Market by Formulation (2018-2032)
6.1 Surgical Hemostat Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Matrix and Gel Hemostats
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Sheet and Pad Hemostats
6.5 Sponge Hemostats
6.6 Powder Hemostats
Chapter 7: Surgical Hemostat Market by End-User (2018-2032)
7.1 Surgical Hemostat Market Snapshot and Growth Engine
7.2 Market Overview
7.3 Hospitals & ASCs
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
7.3.3 Key Market Trends, Growth Factors, and Opportunities
7.3.4 Geographic Segmentation Analysis
7.4 Tactical Combat Casualty Care Centers
7.5 Others
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Surgical Hemostat Market Share by Manufacturer (2024)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 CARLSBERG GROUP (DENMARK)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 ANHEUSER-BUSCH INBEV (BELGIUM)
8.4 SAMUEL ADAMS (UNITED STATES)
8.5 OETTINGER BREWERY (GERMANY)
8.6 ERDINGER BREWERY (GERMANY)
8.7 RADEBERGER BREWERY (GERMANY)
8.8 HEINEKEN (NETHERLANDS)
8.9 DIAGEO PLC (UNITED KINGDOM)
8.10 LASCO BREWERY (EUROPE)
8.11 TRIDENT NITRO (UNITED STATES)
8.12 PABST BLUE RIBBON (UNITED STATES)
8.13 BEAVERTOWN BREWERY (UNITED KINGDOM)
8.14 LAGUNITAS (UNITED STATES)
8.15 AND OTHER MAJOR PLAYERS .
Chapter 9: Global Surgical Hemostat Market By Region
9.1 Overview
9.2. North America Surgical Hemostat Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size by Product Type
9.2.4.1 Thrombin Based
9.2.4.2 Oxidized Regenerated Cellulose Based
9.2.4.3 Gelatin Based
9.2.4.4 Collagen Based Hemostat
9.2.4.5 Others
9.2.5 Historic and Forecasted Market Size by Application
9.2.5.1 Neurological Surgery
9.2.5.2 Orthopedic Surgery
9.2.5.3 Cardiovascular Surgery
9.2.5.4 Gynecological Surgery
9.2.5.5 Trauma
9.2.5.6 Plastic Surgery
9.2.5.7 Others
9.2.6 Historic and Forecasted Market Size by Formulation
9.2.6.1 Matrix and Gel Hemostats
9.2.6.2 Sheet and Pad Hemostats
9.2.6.3 Sponge Hemostats
9.2.6.4 Powder Hemostats
9.2.7 Historic and Forecasted Market Size by End-User
9.2.7.1 Hospitals & ASCs
9.2.7.2 Tactical Combat Casualty Care Centers
9.2.7.3 Others
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Surgical Hemostat Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size by Product Type
9.3.4.1 Thrombin Based
9.3.4.2 Oxidized Regenerated Cellulose Based
9.3.4.3 Gelatin Based
9.3.4.4 Collagen Based Hemostat
9.3.4.5 Others
9.3.5 Historic and Forecasted Market Size by Application
9.3.5.1 Neurological Surgery
9.3.5.2 Orthopedic Surgery
9.3.5.3 Cardiovascular Surgery
9.3.5.4 Gynecological Surgery
9.3.5.5 Trauma
9.3.5.6 Plastic Surgery
9.3.5.7 Others
9.3.6 Historic and Forecasted Market Size by Formulation
9.3.6.1 Matrix and Gel Hemostats
9.3.6.2 Sheet and Pad Hemostats
9.3.6.3 Sponge Hemostats
9.3.6.4 Powder Hemostats
9.3.7 Historic and Forecasted Market Size by End-User
9.3.7.1 Hospitals & ASCs
9.3.7.2 Tactical Combat Casualty Care Centers
9.3.7.3 Others
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Surgical Hemostat Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size by Product Type
9.4.4.1 Thrombin Based
9.4.4.2 Oxidized Regenerated Cellulose Based
9.4.4.3 Gelatin Based
9.4.4.4 Collagen Based Hemostat
9.4.4.5 Others
9.4.5 Historic and Forecasted Market Size by Application
9.4.5.1 Neurological Surgery
9.4.5.2 Orthopedic Surgery
9.4.5.3 Cardiovascular Surgery
9.4.5.4 Gynecological Surgery
9.4.5.5 Trauma
9.4.5.6 Plastic Surgery
9.4.5.7 Others
9.4.6 Historic and Forecasted Market Size by Formulation
9.4.6.1 Matrix and Gel Hemostats
9.4.6.2 Sheet and Pad Hemostats
9.4.6.3 Sponge Hemostats
9.4.6.4 Powder Hemostats
9.4.7 Historic and Forecasted Market Size by End-User
9.4.7.1 Hospitals & ASCs
9.4.7.2 Tactical Combat Casualty Care Centers
9.4.7.3 Others
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Surgical Hemostat Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size by Product Type
9.5.4.1 Thrombin Based
9.5.4.2 Oxidized Regenerated Cellulose Based
9.5.4.3 Gelatin Based
9.5.4.4 Collagen Based Hemostat
9.5.4.5 Others
9.5.5 Historic and Forecasted Market Size by Application
9.5.5.1 Neurological Surgery
9.5.5.2 Orthopedic Surgery
9.5.5.3 Cardiovascular Surgery
9.5.5.4 Gynecological Surgery
9.5.5.5 Trauma
9.5.5.6 Plastic Surgery
9.5.5.7 Others
9.5.6 Historic and Forecasted Market Size by Formulation
9.5.6.1 Matrix and Gel Hemostats
9.5.6.2 Sheet and Pad Hemostats
9.5.6.3 Sponge Hemostats
9.5.6.4 Powder Hemostats
9.5.7 Historic and Forecasted Market Size by End-User
9.5.7.1 Hospitals & ASCs
9.5.7.2 Tactical Combat Casualty Care Centers
9.5.7.3 Others
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Surgical Hemostat Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size by Product Type
9.6.4.1 Thrombin Based
9.6.4.2 Oxidized Regenerated Cellulose Based
9.6.4.3 Gelatin Based
9.6.4.4 Collagen Based Hemostat
9.6.4.5 Others
9.6.5 Historic and Forecasted Market Size by Application
9.6.5.1 Neurological Surgery
9.6.5.2 Orthopedic Surgery
9.6.5.3 Cardiovascular Surgery
9.6.5.4 Gynecological Surgery
9.6.5.5 Trauma
9.6.5.6 Plastic Surgery
9.6.5.7 Others
9.6.6 Historic and Forecasted Market Size by Formulation
9.6.6.1 Matrix and Gel Hemostats
9.6.6.2 Sheet and Pad Hemostats
9.6.6.3 Sponge Hemostats
9.6.6.4 Powder Hemostats
9.6.7 Historic and Forecasted Market Size by End-User
9.6.7.1 Hospitals & ASCs
9.6.7.2 Tactical Combat Casualty Care Centers
9.6.7.3 Others
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Surgical Hemostat Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size by Product Type
9.7.4.1 Thrombin Based
9.7.4.2 Oxidized Regenerated Cellulose Based
9.7.4.3 Gelatin Based
9.7.4.4 Collagen Based Hemostat
9.7.4.5 Others
9.7.5 Historic and Forecasted Market Size by Application
9.7.5.1 Neurological Surgery
9.7.5.2 Orthopedic Surgery
9.7.5.3 Cardiovascular Surgery
9.7.5.4 Gynecological Surgery
9.7.5.5 Trauma
9.7.5.6 Plastic Surgery
9.7.5.7 Others
9.7.6 Historic and Forecasted Market Size by Formulation
9.7.6.1 Matrix and Gel Hemostats
9.7.6.2 Sheet and Pad Hemostats
9.7.6.3 Sponge Hemostats
9.7.6.4 Powder Hemostats
9.7.7 Historic and Forecasted Market Size by End-User
9.7.7.1 Hospitals & ASCs
9.7.7.2 Tactical Combat Casualty Care Centers
9.7.7.3 Others
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Global Surgical Hemostat Market |
|||
|
Base Year: |
2024 |
Forecast Period: |
2025-2032 |
|
Historical Data: |
2018 to 2023 |
Market Size in 2024: |
USD 5.25 Bn. |
|
Forecast Period 2024-32 CAGR: |
6.9 % |
Market Size in 2032: |
USD 8.95 Bn. |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By Formulation |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
